| Mirvetuximab Soravtansine investigated in trials for …INVESTIGATED_IN_TRIALSderived17 of 17show fewer |
|---|
| → investigated in trials for | Malignant Fallopian Tube Neoplasm 11 trials (5 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Malignant Fallopian Tube Neoplasm | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ovarian Carcinomasubtype 9 trials (2 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Ovarian Carcinoma | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Malignant Ovarian Neoplasm 6 trials (4 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Malignant Ovarian Neoplasm | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Malignant Peritoneal Neoplasmsubtype 5 trials (1 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Malignant Peritoneal Neoplasm | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Malignant Endometrial Neoplasm 3 trials (2 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Malignant Endometrial Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Primary Peritoneal Carcinoma 3 trials (0 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Primary Peritoneal Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Triple-Negative Breast Carcinomamolecular_subtype 3 trials (0 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Triple-Negative Breast Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Endometrial Serous Adenocarcinoma 2 trials (0 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Endometrial Serous Adenocarcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fallopian Tube Carcinoma 2 trials (0 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Fallopian Tube Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Breast Carcinoma 1 trials (0 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Endometrial Adenocarcinoma 1 trials (0 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Endometrial Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Endometrial Clear Cell Adenocarcinoma 1 trials (0 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Endometrial Clear Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fallopian Tube Neoplasmsubtype 1 trials (1 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Fallopian Tube Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Neoplasmcancer_family 1 trials (0 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ovarian Neoplasmsubtype 1 trials (1 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Platinum-Resistant Ovarian Carcinoma 1 trials (0 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Platinum-Resistant Ovarian Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Uterine Carcinosarcoma 1 trials (0 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Uterine Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |